Second malignancies after Hodgkin's disease: The Munich experience

Annals of Hematology

Volumn 78, Issue 12, 1999, Pages 544-554

  Munker, R ^a   Grutzner S ^a   Hiller, E ^a   Aydemir, U ^a   Enne, W ^a   Dietzfelbinger, H ^a   Busch, M ^a   Haas, R ^a   Emmerich, B ^a   Schmidt, M ^a   Duhmke E ^a   Holzel D ^a   Wilmanns, W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Hodgkin's disease; Second malignancies; Splenectomy

Indexed keywords

CYTOTOXIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CHILD; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; INFANT; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCHOOL CHILD; SECOND CANCER; SOLID TUMOR; SPLENECTOMY; SURVIVAL TIME; THYROID CANCER;

EID: 0342905432     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050556     Document Type: Article

References (54)

1. Abrahamsen JF, Andersen A, Hannisdal E, et al. (1993) Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time and age. J Clin Oncol 11:255-261
2. Adnan E, Nicholas S, Madras R. et al. (1996) Synchronous Hodgkin's disease and non-Hodgkin's lymphoma. Acta Oncol 35:755-757
3. Aisenberg AC, Finkelstein DM, Doppke KP, et al. (1997) High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 79:1203-1210
4. Amini RM, Enblad G, Sundström C, et al. (1997) Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphomas: a clinico-pathological and immuno-histo-chemical population-based study of 32 patients. Int J Cancer 71:510-516
5. Beaty III O, Hudson MM, Greenwald C, et al. (1995) Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609
6. Bennett MH, MacLennan KA, Vaughan Hudson G, et al. (1991) Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. Ann Oncol 2 [Suppl]: 83-92
7. Biti G, Cellai E, Magrini SM, et al. (1994) Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution. Int J Rad Oncol Biol Phys 29:25-31
8. Blayney DW, Longo DL, Young RC, et al. 1987) Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 316:710-714
9. Boivin JF, Hutchison GB, Zauber AG, et al. (1995) Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732-741
10. Bouabdallah K, Marit G, Reiffers J, et al. (1991) Hodgkin's disease and secondary Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer Genet Cytogenet 55:277-278
11. Canellos GP, de Vita VT, Arseneaux JC, et al. (1975) Second malignancies complicating Hodgkin's disease in remission. Lancet 1:947-949
12. Castellino RA (1992) Diagnostic imaging studies in patients with newly diagnosed Hodgkin's disease. Ann Oncol 3 [Suppl 4]: 45-47
13. Chung CT, Bogart JA, Adams JF, et al. (1997) Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Rad Oncol Biol Phys 37:405-409
14. Davis TH, Morton CC, Miller-Cassman R, et al. (1992) Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115-1122
15. de Benedetti VMG, Travis LB, Welsh JA, et al. (1996) p53 mutations in lung cancer following radiation therapy for Hodgkin's disease. Cancer Epidemiol Biomarkers Prev 5:93-98
16. Dietrich PY, Henry-Amar M, Cosset JM, et al. (1994) Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood 84:1209-1215
17. Doria R, Holford T, Farber LR, et al. (1995) Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol 13:2016-2022
18. Fries S, Aydemir Ü, Schmidt M, et al. (1999) Risk of basal cell carcinoma after Hodgkin's disease (submitted for publication)
19. Gerl A, Clemm C, Salat C, et al. (1993) Testicular cancer and Hodgkin's disease in the same patient. Cancer 71:2838-2840
20. Goss PE, Sierra S (1998) Current perspectives on radiation-induced breast cancer. J Clin Oncol 16:338-347
21. Hancock SL, Tucker MA, Hoppe RT (1993) Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31
22. Hansmann ML, Fellbaum CH, Hui PK, et al. (1989) Morphological and immuno-histochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease. Histopathology 15:35-48
23. Henry-Amar M, on behalf of the IDHD (1990) Second cancer after the treatment of Hodgkin's disease: the experience of the British national lymphoma investigation. Br Med J 301:1077-1080
24. Henry-Amar M, Dietrich PY (1993) Acute leukemia after the treatment of Hodgkin's disease. Hematol Oncol Clin North Am 7:369-387
25. Heyssel R, Brill AB, Woodbury LA, et al. (1960) Leukemia in Hiroshima atomic bomb survivors. Blood 15:313-331
26. Kaldor JM, Day NE, Band P, et al. (1987) Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 39:571-585
27. Kaldor JM, Day NE, Bell J, et al. (1992) Lung cancer following Hodgkin's disease: a case-control study. Int J Cancer 52:677-681
28. List AF, Doll DC, Greco FA (1985) Lung cancer in Hodgkin's disease: association with previous radiotherapy. J Clin Oncol 3:215-221
29. Liu Y, Hernandez M, Shibata D, et al. (1994) Bcl-2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A 91:8910-8914
30. Löffler M, Diehl V, Pfreundschuh M, et al. (1997) Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease. J Clin Oncol 15:2275-2287
31. Mauch PM, Kalish LA, Marcus KC, et al. (1996) Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 87:3625-3632
32. Mellemkjoer L, Olsen J, Linet MS, et al. (1995) Cancer risk after splenectomy. Cancer 75:577-583
33. Miettinen M, Franssila KO, Saxen E (1983) Hodgkin's disease lymphocytic predominance nodular: increased risk for subsequent non-Hodgkin's lymphomas. Cancer 51:2293-2300
34. Munker R, Hasenclever D, Brosteanu O, et al. (1994) Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. J Clin Oncol 13:403-409
35. Munker R, Stengel A, Stäbler A, et al. (1995) Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Cancer 76:1460-1466
36. Munker R, Hiller E, Melnyk A, et al. (1996) Second malignancies: clinical relevance and basic research. Int J Oncol 9:763-776
37. Nishikubo CY, Kunkel LA, Figlin R, et al. (1996) An association between renal cell carcinoma and lymphoid malignancies. Cancer 78:2421-2426
38. Punt CJA, Rozenberg-Arska M, Verdonck LF (1987) Successful treatment with chemotherapy and subsequent allogeneic bone marrow transplantation for myeloid blastic crisis of chronic myelogenous leukemia following advanced Hodgkin's disease. Cancer 60:934-935
39. Rodriguez MA, Fuller LM, Zimmerman SO, et al. (1993) Hodgkin's disease: study of treatment intensities and incidence of second malignancies. Ann Oncol 4:125-131
40. Salloum E, Doria R, Schubert W, et al. (1996) Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 14:2435-2443
41. Schellong G, Hörnig-Franz I, Riepenhausen M. et al. (1994) Reduzierung der Strahlendosen auf 20-30 Gy im Rahmen einer Kombination (Chemo + Radiotherapie) bei M. Hodgkin im Kindesalter. Klin Padiatr 206:253-262
42. Schellong G, Riepenhausen MU, Creutzig, et al. (1997) Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. J Clin Oncol 15:2247-2253
43. Sont JK, van Stiphout WAHJ, Noordijk EM, et al. (1992) Increased risk of second cancers in managing Hodgkin's disease: the 20-year Leiden experience. Ann Hematol 65:213-218
44. Swerdlow AJ, Barber JA, Horwich A, et al. (1997) Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 75:116-123
45. Travis LB, Curtis RE, Bennett WP, et al. (1995) Lung cancer after Hodgkin's disease. J Natl Cancer Inst 87:1324-1327
46. Tucker MA, Coleman CN, Cox RS, et al. (1988) Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81
47. Tura S, Fiacchini M, Zinzani PL, et al. (1993) Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 11:925-930
48. Valagussa P, Santoro A, Fossati-Bellani F (1986) Second acute leukemia and other malignancies following treatment for Hodgkin's disease J Clin Oncol 6:830-837
49. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. (1994) Second cancer risk following Hodgkin's disease: a 20 year follow-up study. J Clin Oncol 12:312-325
50. van Leeuwen FE, Klokman WJ, Stovall M, et al. (1995) Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 87:1530-1537
51. Waghorn DJ and Mayon-White RT (1997) A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed? J Infect 35:289-294
52. Wolden SL, Lamborn KR, Cleary SF, et al. (1998) Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16:536-544
53. Yahalom J, Petrek JA, Biddinger PW, et al. (1992) Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 10:1674-1681
54. Zarate-Osorno A, Medeiros LJ, Longo DL, et al. (1992) Non-Hodgkin's lymphomas arising in patients successfully treated for Hodgkin's disease. Am J Surg Pathol 16:885-895